Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel zinc-mediated dechlorination and Mitsunobu strategy for trans-4-(5-bromo-2-chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclohexanol. Enhances yield to 46.4% and reduces heavy metal reliance.
Patent CN105734089A reveals enzymatic synthesis for pharmaceutical intermediates. Offers high optical purity and scalable production for global supply chains.
Patent CN101817835A details a novel Cefdinir preparation method using Pentafluorophenol activation, offering significant cost reduction in antibiotic manufacturing and enhanced supply chain reliability.
Patent CN101045733B reveals a high-yield synthesis of Cefotiam Dihydrochloride via ATC.HCl acylation, offering significant cost reduction and supply chain reliability for antibiotic manufacturers.
Novel alkaline hydrolysis route for azelastine intermediate improves yield to 65.9% and reduces environmental impact for reliable supply.
Patent CN110003080B reveals a novel copper-catalyzed C5/C6 selenization method for indolines and tetrahydroquinolines, offering high yields and significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN103435568A reveals a greener synthesis route for Vitamin B6 intermediates. Achieve higher purity and reduced environmental impact with scalable manufacturing.
Patent CN114277023B details a biocatalytic route for nicotinamide using recombinant enzymes and ion exchange resin for superior purity and cost efficiency.
Patent CN101215284B reveals a vacuum reflux method boosting Eprosartan yield to 85% and purity to 98%, offering significant cost reduction in antihypertensive API manufacturing.
Patent CN102432485B details a novel Rh-catalyzed four-component reaction for high-purity alpha,beta-diamino acid derivatives, offering significant cost reduction in API manufacturing.
Advanced synthesis of 1,4,7-triazacyclononane hydrochloride via patent CN104529922A. Delivers high yield, stability, and cost reduction in pharmaceutical intermediate manufacturing.
Advanced preparation of 5-chloroacetamide-N,N'-bi(2,3-dihydroxyl propyl)-2,4,6-triiodo-1,3-benzenedicarboxamide via optimized acyl chloride pathway for cost-effective contrast media manufacturing.
Patent CN112679477B reveals a greener route for Selinexor intermediates, offering cost reduction and supply chain reliability for API manufacturers.
Patent CN112159831B reveals cost-effective enzymatic NMN synthesis. Discover supply chain advantages and high-purity manufacturing capabilities for global buyers.
Patent CN105601640A details scalable spiro compound synthesis. Offers cost reduction and high purity for pharmaceutical intermediate manufacturing supply chains.
Patent CN103242215A details a safer transfer hydrogenation route for Lenalidomide intermediates, offering significant cost reduction and simplified supply chain management for pharmaceutical manufacturers.
Advanced synthesis route for cardiovascular drug intermediates offering scalable production and cost efficiency for global pharmaceutical supply chains.
Patent CN105669732B reveals a scalable 3-step synthesis for Anacetrapib intermediates. Discover cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN107417613A reveals copper-catalyzed route. High yield, mild conditions. Ideal for pharma intermediate supply chain optimization and cost reduction.
Patent CN106749027A reveals improved yield and reduced waste for dexmedetomidine intermediate manufacturing supply chain.